Paradox breaker BRAF inhibitors have comparable potency and MAPK pathway reactivation to encorafenib in BRAF mutant colorectal cancer
Paradox breaker BRAF inhibitors have comparable potency and MAPK pathway reactivation to encorafenib in BRAF mutant colorectal cancer |
https://doi.org/10.18632/oncotarget.27681
Oliver J. Pickles,
Aneta Drozd,
Louise Tee,
Andrew D. Beggs,
and Gary W. Middleton
|
3188-3197 |
Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers
Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers |
https://doi.org/10.18632/oncotarget.27682
Takeyuki Suzuki,
Tetsutaro Suzuki,
Yukino Yoshimura,
Mitsunori Yahata,
Poh Yin Yew,
Tetsuya Nakamura,
Yusuke Nakamura,
Jae-Hyun Park,
and Ryota Matsuo
|
3198-3207 |
The NKL-code for innate lymphoid cells reveals deregulated expression of NKL homeobox genes HHEX and HLX in anaplastic large cell lymphoma (ALCL)
The NKL-code for innate lymphoid cells reveals deregulated expression of NKL homeobox genes HHEX and HLX in anaplastic large cell lymphoma (ALCL) |
https://doi.org/10.18632/oncotarget.27683
Stefan Nagel,
Claudia Pommerenke,
Roderick A.F. MacLeod,
Corinna Meyer,
Maren Kaufmann,
and Hans G. Drexler
|
3208-3226 |
Differentially expressed full-length, fusion and novel isoforms transcripts-based signature of well-differentiated keratinized oral squamous cell carcinoma
Differentially expressed full-length, fusion and novel isoforms transcripts-based signature of well-differentiated keratinized oral squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.27693
Neetu Singh,
Dinesh Kumar Sahu,
Ratnesh Kumar Tripathi,
Archana Mishra,
Hari Shyam,
Pratap Shankar,
Mayank Jain,
Nawazish Alam,
Anil Kumar,
Abhishek Mishra,
Rebecca Chowdhry,
Anjana Singh,
Sameer Gupta,
Divya Mehrotra,
Preeti Agarwal,
Madhu Mati Goel,
Arun Chaturvedi,
Satya Prakash Agarwal,
Manish Bajpai,
Devendra Kumar Gupta,
Madan Lal Brahma Bhatt,
and Ravi Kant
|
3227-3243 |
Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1
Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1 |
https://doi.org/10.18632/oncotarget.27696
Gajanan Sathe,
Irene A. George,
Barnali Deb,
Ankit P. Jain,
Krishna Patel,
Brusabhanu Nayak,
Subhradip Karmakar,
Amlesh Seth,
Akhilesh Pandey,
and Prashant Kumar
|
3244-3255 |
A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy
A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy |
https://doi.org/10.18632/oncotarget.27701
Matteo Torresetti,
Donatella Brancorsini,
Francesca Morgese,
Valeria Cognigni,
Alessandro Scalise,
Rossana Berardi,
and Giovanni Di Benedetto
|
3256-3262 |
Correction: MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression
Correction: MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression |
https://doi.org/10.18632/oncotarget.27729
Chang Li,
Lei Song,
Zhuo Zhang,
Xiao-Xue Bai,
Ming-Fu Cui,
and Lian-Jun Ma
|
3263-3264 |